Myeloid-derived suppressor cells in transplantation tolerance induction

Area of Science:

• Immunology
• Transplantation Biology
• Cell Therapy

Background:

• Myeloid-derived suppressor cells (MDSCs) are immature myeloid cells with potent immunosuppressive functions.
• MDSCs accumulate in pathological conditions like tumors and inflammation, inhibiting effector T cells and promoting regulatory T cells.
• These cells play a crucial role in modulating immune responses relevant to transplant rejection.

Purpose of the Study:

• To review the efficacy of MDSCs in various organ transplantation models.
• To explore the potential of MDSCs in inducing immune tolerance and preventing transplant rejection.
• To discuss the combined use of MDSCs and clinical immunosuppressants for enhanced graft survival.

Main Methods:

• Review of existing literature on MDSC function in transplantation.
• Analysis of studies investigating in vivo and in vitro MDSC induction and transfusion.
• Examination of research on combining MDSCs with immunosuppressive agents.

Main Results:

• MDSCs demonstrate significant immunomodulatory effects in transplantation settings.
• Strategies involving MDSC expansion or transfusion can establish immune tolerance.
• Combination therapy with MDSCs and immunosuppressants shows potential for prolonging graft survival.

Conclusions:

• MDSCs represent a promising therapeutic strategy for managing transplant rejection.
• Targeted use of MDSCs, potentially with conventional immunosuppressants, can improve graft outcomes.
• Further research into MDSC-based therapies is warranted for clinical application in organ transplantation.